Literature DB >> 9529051

An essential role for gamma interferon in innate resistance to Shigella flexneri infection.

S S Way1, A C Borczuk, R Dominitz, M B Goldberg.   

Abstract

Shigella spp. are the major cause of bacillary dysentery worldwide. To identify immune effectors associated with protection of the naive host during infection, the susceptibility to pulmonary Shigella infection of each of various mouse strains that have a targeted deletion in a specific aspect of the immune system was evaluated. Our results demonstrate that mice deficient in gamma interferon are 5 orders of magnitude more susceptible to Shigella than are wild-type mice, whereas mice deficient in B and T lymphocytes or in T lymphocytes alone exhibit no difference in susceptibility. Significantly lower numbers of shigellae were recovered from immunocompetent compared with gamma-interferon-deficient mice after infection. While immunocompetent mice were able to clear a sublethal Shigella inoculum by day 5 postinfection, progressively increasing numbers of shigellae were cultured from the lungs of gamma interferon-deficient mice over the same period. Histopathology of the lungs from immunocompetent mice infected with a sublethal Shigella inoculum showed mild inflammatory changes, whereas the lungs from gamma interferon-deficient mice demonstrated progressively worsening acute bronchiolitis with ulceration. Further, the time to death in gamma interferon-deficient mice correlates inversely with the size of the Shigella inoculum. To identify the cellular source of gamma interferon, we infected SCID mice, T-cell-receptor-deficient mice, beige mice (a mouse strain deficient in natural killer [NK] cell activity), and mice depleted of NK cells using anti-asialo-GM1. Each NK cell-deficient mouse strain exhibited a 10-fold-greater susceptibility to Shigella infection than immunocompetent mice. To test the protective effects of gamma interferon in vitro, survival of intracellular Shigella was examined in primary macrophages from wild-type mice, primary macrophages from gamma interferon-deficient mice, a macrophage cell line, and a fibroblast cell line. Following activation with gamma interferon, each cell type eradicated intracellular Shigella, while nonactivated macrophages fostered Shigella replication and nonactivated fibroblast cells fostered both Shigella replication and intercellular spread. Taken together, these data establish that NK cell-mediated gamma interferon is essential to resistance following primary Shigella infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529051      PMCID: PMC108058     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Experimental pneumonia caused by bacteria of the Shigella group.

Authors:  M V VOINO-YASENETSKY; M K VOINO-YASENETSKAYA
Journal:  Acta Morphol Acad Sci Hung       Date:  1962

2.  Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.

Authors:  R Raqib; A Ljungdahl; A A Lindberg; U Andersson; J Andersson
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

3.  Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp.

Authors:  D W Niesel; C B Hess; Y J Cho; K D Klimpel; G R Klimpel
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

5.  Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri.

Authors:  A T Maurelli; B Baudry; H d'Hauteville; T L Hale; P J Sansonetti
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.

Authors:  M L Bernardini; J Mounier; H d'Hauteville; M Coquis-Rondon; P J Sansonetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.

Authors:  J C Roder
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

9.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

Authors:  G J Bancroft; K C Sheehan; R D Schreiber; E R Unanue
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  Plaque formation by virulent Shigella flexneri.

Authors:  E V Oaks; M E Wingfield; S B Formal
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

View more
  28 in total

1.  Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.

Authors:  Sekar Tamil Selvi Chitradevi; Gurpreet Kaur; Sivaramakrishna Uppalapati; Anandprakash Yadav; Dependrapratap Singh; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

Review 2.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

3.  Clearance of Shigella flexneri infection occurs through a nitric oxide-independent mechanism.

Authors:  S S Way; M B Goldberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ.

Authors:  Nikolay Burnaevskiy; Thomas G Fox; Daniel A Plymire; James M Ertelt; Bethany A Weigele; Andrey S Selyunin; Sing Sing Way; Steven M Patrie; Neal M Alto
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962

Review 5.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence.

Authors:  S S Way; S Sallustio; R S Magliozzo; M B Goldberg
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

7.  Identification of alkA gene related to virulence of Shigella flexneri 2a by mutational analysis.

Authors:  Zhao-Xing Shi; Heng-Liang Wang; Kun Hu; Er-Ling Feng; Xiao Yao; Guo-Fu Su; Pei-Tang Huang; Liu-Yu Huang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases.

Authors:  Roberta Souza Dos Reis; Fabiana Horn
Journal:  Gut Pathog       Date:  2010-07-22       Impact factor: 4.181

9.  Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.

Authors:  Ryan T Ranallo; Robert W Kaminski; Tonia George; Alexis A Kordis; Qing Chen; Kathleen Szabo; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

10.  Unc119 protects from Shigella infection by inhibiting the Abl family kinases.

Authors:  Ramarao Vepachedu; Zunayet Karim; Ojas Patel; Nicholas Goplen; Rafeul Alam
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.